Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung.

Suppr

超能文献

作者信息

Eagan R T, Frytak S, Creagan E T, Ingle J N, Kvols L K, Coles D T

出版信息

Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1589-91.

PMID:227597

Abstract

摘要

相似文献

Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung.

Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1589-91.

Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide in advanced adenocarcinoma and large cell carcinoma of the lung.

Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1983-7.

[Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].

Med Clin (Barc). 1982;79(9):403-6.

cis-Dichlorodiammineplatinum(II) in non-small cell carcinoma of the lung.

Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1585-8.

Chemotherapy for adenocarcinoma and large cell anaplastic carcinoma of the lung with ftorafur, adriamycin, and cis-dichlorodiammineplatinum(II).

Cancer Treat Rep. 1978 Jul;62(7):1089-91.

cis-Dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma: a phase II study.

Cancer Treat Rep. 1979 Apr;63(4):543-5.

Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.

Cancer Treat Rep. 1982 Feb;66(2):247-51.

Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung.

Cancer Treat Rep. 1980 Aug-Sep;64(8-9):925-8.

Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancer.

Cancer Treat Rep. 1983 Apr;67(4):375-6.

[Preliminary phase II study of cis-Dichlorodiammineplatinum (II) in patients with non-small cell carcinoma of the lung and metastatic pulmonary tumor].

Gan No Rinsho. 1984 Sep;30(11):1344-50.

引用本文的文献

Chemotherapy of advanced non-small cell lung cancer. A review.

Invest New Drugs. 1984;2(3):339-47. doi: 10.1007/BF00175389.

A randomized comparison of the effects of adjuvant therapy on resected stages II and III non-small cell carcinoma of the lung. The Lung Cancel Study Group.

Ann Surg. 1985 Sep;202(3):335-41. doi: 10.1097/00000658-198509000-00010.

Combination chemotherapy for advanced adenocarcinoma of the lung. A review.

Cancer Chemother Pharmacol. 1988;21(2):103-16. doi: 10.1007/BF00257355.

Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.

Cancer Chemother Pharmacol. 1986;18 Suppl 2:S34-9. doi: 10.1007/BF00647449.

Update in cancer chemotherapy, Part III: Lung cancer, Part 1.

J Natl Med Assoc. 1985 Oct;77(10):815-27.

The benefit of cisplatin-based polychemotherapy for adenocarcinoma of the lung. The Kyushu Lung Cancer Chemotherapy Study Group.

Cancer Chemother Pharmacol. 1990;26(1):47-51. doi: 10.1007/BF02940293.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验